Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of omeprazole 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an index.

Trial Profile

Study of the improvement effect of proton pump inhibitors on symptoms in patients with reflux esophagitis (RE): a randomized comparative study of omeprazole 20mg vs. rabeprazole 10mg using the time (number of days) to improvement in symptoms as an index.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Dec 2014

At a glance

  • Drugs Omeprazole (Primary) ; Rabeprazole (Primary)
  • Indications Reflux oesophagitis
  • Focus Therapeutic Use
  • Acronyms J-DYSPEPSIA-STUDY5
  • Most Recent Events

    • 06 Mar 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 31 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 09 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top